← Back to headlines
Apellis Pharma Stock Surges Following Biogen Deal
Apellis Pharma's stock has seen a significant surge following a deal with Biogen, leading investors to question if it's too late to capitalize on the APLS stock rally.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
IBC 13 Launches TreZe, a New Multimedia News Initiative for Gen Z
just now
Filipino Youth Oppose Social Media Restrictions, Survey Finds
just now
AI Startup Cursor Seeks $2 Billion Funding Round at Over $50 Billion Valuation
19m ago